oxidized glutathione odor compared to reduced glutathione Quantitation of and in plasma by micellar electrokinetic capillary electrophoresis oxidized glutathione odor compared to – Differentiating Changes in Glutathione Levels

Absolute Contraindications Active malignancy Pregnancy and lactation Severe hypoglycemia disorders Known hypersensitivity to IGF-1 Active proliferative retinopathy Relative Contraindications Diabetes mellitus Renal impairment Cardiac impairment History of hyperplasia Family history of certain cancers Severe hepatic impairment Dosing & Administration Starting Dose 2050 mcg/day subcutaneously Begin at the lower end for sensitive patients Assess tolerance for 12 weeks before titration Therapeutic Range 50120 mcg/day for most indications Maximum dose: 200 mcg/day Individualize dosing based on response and tolerance Cycling Protocol 46 weeks on therapy 4 weeks off therapy Helps prevent receptor desensitization Supports long-term efficacy Administration Guidelines Hypoglycemia Prevention: Always administer IGF-1 LR3 with or shortly after carbohydrate-containing meals

[1] [3] This sterile injectable solution may be intended for use in patients requiring enhanced antioxidant support, detoxification, or adjunctive therapy in specific medical conditions

To maintain transparency and uphold our quality standards, we provide Certificates of Analysis (COAs) issued by an independent, accredited laboratory

Who Should Consider Skin Brightening IVs

How IGF-1 LR3 Works IGF-1 LR3 functions by binding to the IGF-1 receptor, activating intracellular signaling pathways that promote protein synthesis, muscle fiber hypertrophy, and nutrient uptake